Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oral nano‐curcumin formulation efficacy in the management of mild to moderate outpatient COVID‐19: A randomized triple‐blind placebo‐controlled clinical trial
رضا احمدی, Soofia Salari, Mohammad Davood Sharifi, et al.
Food Science & Nutrition (2021) Vol. 9, Iss. 8, pp. 4068-4075
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials
Amir Vahedian‐Azimi, Mitra Abbasifard, Farshid Rahimi‐Bashar, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 256-256
Open Access | Times Cited: 115
Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
Mangala Hegde, Sosmitha Girisa, Bandari BharathwajChetty, et al.
ACS Omega (2023) Vol. 8, Iss. 12, pp. 10713-10746
Open Access | Times Cited: 98
Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials
Ajaikumar B. Kunnumakkara, Mangala Hegde, Parama Dey, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 4, pp. 447-518
Open Access | Times Cited: 78
Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 229-229
Open Access | Times Cited: 48
Effect of nano‐curcumin on various diseases: A comprehensive review of clinical trials
Shirin Hassanizadeh, Mehrnaz Shojaei, Mohammad Bagherniya, et al.
BioFactors (2023) Vol. 49, Iss. 3, pp. 512-533
Closed Access | Times Cited: 39
The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial
Gholamreza Askari, Amirhossein Sahebkar, Davood Soleimani, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 43
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Curcumin Extraction, Isolation, Quantification and Its Application in Functional Foods: A Review With a Focus on Immune Enhancement Activities and COVID-19
Soubhagya Tripathy, Deepak Kumar Verma, Mamta Thakur, et al.
Frontiers in Nutrition (2021) Vol. 8
Open Access | Times Cited: 44
An updated and comprehensive review on the potential health effects of curcumin-encapsulated micro/nanoparticles
Ahmed K. Rashwan, Naymul Karim, Yang Xu, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 29, pp. 9731-9751
Closed Access | Times Cited: 31
Food Plant Secondary Metabolites Antiviral Activity and Their Possible Roles in SARS-CoV-2 Treatment: An Overview
Deborah Giordano, Angelo Facchiano, Virginia Carbone
Molecules (2023) Vol. 28, Iss. 6, pp. 2470-2470
Open Access | Times Cited: 16
Nanomedicine for the Treatment of Viral Diseases: Smaller Solution to Bigger Problems
Suvankar Ghorai, Harshita Shand, Soumendu Patra, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 407-407
Open Access | Times Cited: 5
Microglial activation states and their implications for Alzheimer's Disease
Zachary Valiukas, Kathy Tangalakis, Vasso Apostolopoulos, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100013-100013
Open Access
Harnessing bioactive nanocurcumin and curcumin nanocomposites to combat microbial pathogens: a comprehensive review
Mahendra Rai, Chistiane Mendes Feitosa, Avinash P. Ingle, et al.
Critical Reviews in Biotechnology (2025), pp. 1-23
Closed Access
Natural products as potential therapeutic agents against microplastic-induced neurodegenerative disease
Melike Kücükkarapinar, Helmuth Reuter
Studies in natural products chemistry (2025), pp. 425-459
Closed Access
Probiotics and prebiotics: potential prevention and therapeutic target for nutritional management of COVID-19?
Kamila Sabino Batista, Juliana Gondim de Albuquerque, Maria Helena Araújo de Vasconcelos, et al.
Nutrition Research Reviews (2021) Vol. 36, Iss. 2, pp. 181-198
Open Access | Times Cited: 36
Phenolic compounds versus SARS-CoV-2: An update on the main findings against COVID-19
Vicente Amirpasha Tirado-Kulieva, Ernesto Hernández, Tania Jakeline Choque Rivera
Heliyon (2022) Vol. 8, Iss. 9, pp. e10702-e10702
Open Access | Times Cited: 26
Bioactive Compounds from the Zingiberaceae Family with Known Antioxidant Activities for Possible Therapeutic Uses
Raphael N. Alolga, Feizuo Wang, Xinyao Zhang, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1281-1281
Open Access | Times Cited: 25
Curcumin for the treatment of COVID‐19 patients: A meta‐analysis of randomized controlled trials
Arman Shafiee, Mohammad Mobin Teymouri Athar, Abia Shahid, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 3, pp. 1167-1175
Closed Access | Times Cited: 13
The effectiveness of nano‐curcumin on patients with COVID‐19: A systematic review of clinical trials
Mehrnaz Shojaei, Sahar Foshati, Mohaddese Abdi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 4, pp. 1663-1677
Open Access | Times Cited: 13
Immunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19
Fahimeh Lavi Arab, Akram Hoseinzadeh, Fatemeh Mohammadi, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116131-116131
Open Access | Times Cited: 4
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial
Ikram Din Ujjan, Saeed Khan, Roohi Nigar, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 11
Nanocurcumin supplementation improves pulmonary function in severe COPD patients: A randomized, double blind, and placebo‐controlled clinical trial
Mahdieh Zare'i, Masoumeh Rabieepour, R. Ghareaghaji, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1224-1234
Closed Access | Times Cited: 3
Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a mechanistic review
Ibrahim Jantan, Nor Azrina Norahmad, Yuandani Yuandani, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-26
Closed Access | Times Cited: 3
The effects of curcumin as dietary supplement for patients with COVID-19: A systematic review of randomized clinical trials
Basel Abdelazeem, Ahmed K. Awad, Merihan A. Elbadawy, et al.
Drug Discoveries & Therapeutics (2022) Vol. 16, Iss. 1, pp. 14-22
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top